2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Polycystic Ovary Syndrome
13
Insulin Resistance
3
Hyperandrogenism
3
Metabolic Syndrome
2
Solid Tumors
1
Primary Dysautonomias
1
Overweight
1
Observational Study
1
Motor Activity
1
Menstruation Disturbances
1
Infertility
1
Hirsutism
1
Endometrial Neoplasms
1
Depression
1
Breast Neoplasms
1
Bipolar Disorder
1
Anxiety Disorders
1
Advanced Malignancies
1
Interventions
ziprasidone
1
drospirenone
1
Zolpidem
1
Warfarin
1
Venlafaxine Hydrochloride
1
Vecuronium Bromide
1
Vancomycin
1
Tranexamic Acid
1
Tobramycin
1
Surveys and Questionnaires
1
Spironolactone
1
Sevelamer
1
Saline Solution
1
Rocuronium
1
Piperacillin, Tazobactam Drug Combination
1
Pentobarbital
1
Oxycodone
1
Nifedipine
1
Nafcillin
1
Molindone
1
Methylprednisolone
1
Metformin
1
Medical Marijuana
1
Lurasidone Hydrochloride
1
Labetalol
1
Infliximab
1
Haloperidol
1
Gabapentin
1
Fosfomycin
1
Exercise
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Bipolar Disorder
×
Ethinyl Estradiol
×
Clear all
NCT04984070
2022-10-05
PCOS
Fudan University
Phase NA
Unknown
100 enrolled